ZA945417B - Method of inhibiting cellular entry of human immunodeficiency viruses NHIV) in HIV seropositive humans. - Google Patents

Method of inhibiting cellular entry of human immunodeficiency viruses NHIV) in HIV seropositive humans.

Info

Publication number
ZA945417B
ZA945417B ZA945417A ZA945417A ZA945417B ZA 945417 B ZA945417 B ZA 945417B ZA 945417 A ZA945417 A ZA 945417A ZA 945417 A ZA945417 A ZA 945417A ZA 945417 B ZA945417 B ZA 945417B
Authority
ZA
South Africa
Prior art keywords
nhiv
human immunodeficiency
immunodeficiency viruses
inhibiting cellular
cellular entry
Prior art date
Application number
ZA945417A
Inventor
Alison Mary Badger
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ZA945417B publication Critical patent/ZA945417B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA945417A 1993-07-23 1994-07-22 Method of inhibiting cellular entry of human immunodeficiency viruses NHIV) in HIV seropositive humans. ZA945417B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939315351A GB9315351D0 (en) 1993-07-23 1993-07-23 Methods

Publications (1)

Publication Number Publication Date
ZA945417B true ZA945417B (en) 1995-05-10

Family

ID=10739366

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA945417A ZA945417B (en) 1993-07-23 1994-07-22 Method of inhibiting cellular entry of human immunodeficiency viruses NHIV) in HIV seropositive humans.

Country Status (9)

Country Link
EP (1) EP0717622A4 (en)
JP (1) JPH09500646A (en)
CN (1) CN1130873A (en)
AU (1) AU7514094A (en)
CA (1) CA2167843A1 (en)
GB (1) GB9315351D0 (en)
NZ (1) NZ271496A (en)
WO (1) WO1995003049A1 (en)
ZA (1) ZA945417B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9315340D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315306D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
BR9601909A (en) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N, n-diethyl-8,8-dipropyl-2-azaspiro (4,5) decane-2-propan amine dimaleate
WO1997044030A1 (en) * 1996-05-17 1997-11-27 Anormed Inc. Use of substituted azaspirane in the treatment of asthma

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
GB9201803D0 (en) * 1992-01-28 1992-03-11 Smithkline Beecham Corp Methods
GB9201804D0 (en) * 1992-01-28 1992-03-11 Smithkline Beecham Corp Methods
GB9315340D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315306D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315341D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods

Also Published As

Publication number Publication date
WO1995003049A1 (en) 1995-02-02
EP0717622A1 (en) 1996-06-26
NZ271496A (en) 1999-06-29
JPH09500646A (en) 1997-01-21
AU7514094A (en) 1995-02-20
GB9315351D0 (en) 1993-09-08
EP0717622A4 (en) 1998-09-09
CN1130873A (en) 1996-09-11
CA2167843A1 (en) 1995-02-02

Similar Documents

Publication Publication Date Title
EP0676954A4 (en) Human immunodeficiency virus decoy.
NO954635L (en) Ribozyme therapy for HIV infections and AIDS
NO985200L (en) Antimicrobial treatment for herpes simplex virus, and other infectious diseases
DK0973735T3 (en) Polyaromatic antiviral preparations
ZA936592B (en) Nutrition for persons infected with human immunodeficiency virus
IL102092A0 (en) Vaccine and treatment method for human immunodeficiency virus
KR970702919A (en) Recombinant Human Immunodeficiency Virus Vector and Process for Producing the same
ZA964679B (en) Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection.
NZ307494A (en) Lymphokine capable of inhibiting immunodeficiency viruses
EP0608212A4 (en) Method of treating viral infection.
FI935780A (en) HIV protease inhibitors useful in the treatment of AIDS
GB9304746D0 (en) Treatment of viral infections
EP0675953A4 (en) Soluble peptides having constrained, secondary conformation in solution and method of making same.
IL109437A0 (en) 2-Amino-4-quinolyldihydropyridines, processes for their preparation and their use
ZA945417B (en) Method of inhibiting cellular entry of human immunodeficiency viruses NHIV) in HIV seropositive humans.
EP1202750A4 (en) Method of treating hiv infection and related secondary infections thereof
HUT69056A (en) Cyclic-acetals, process for their preparation and their use as herbicides
ZA945416B (en) Method of inhibiting the production of infectious human immunodeficiency viruses (HIV) in HIV seropositive humans.
IL110967A0 (en) Substituted tetronic acids useful for treating hiv and other retroviruses
ZA945418B (en) Method of inhibiting the replication of human immunodeficiency viruses (HIV) in HIV seropositive humans.
EP0726715A4 (en) Psyllium containing snack bars, processes for making these, and uses thereof
PL317876A1 (en) Combined treatment of hiv infections
EP0674657A4 (en) Gp41 mutants and their use as hiv therapeutics.
EP0637031A3 (en) Parallel processor and method of fabrication.
AU5000796A (en) Process for the deactivation of hiv and other viruses